Journal of Hepatology

Displaying 1 - 17 of 17
Cao, Z., Yao, Y., Cai, M., Zhang, C., Liu, Y., Xin, H., An, B., Wang, H., Lu, Y., Li, Z., Chen, Y., Huang, Y., Xin, M., Li, R., Qian, Z., Zhou, Y., Xiang, X., Moreau, R., & Xie, Q. (2024). Blood markers for type-1,-2, and -3 inflammation are associated with severity of acutely decompensated cirrhosis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2024.10.028
Publication Date
Rezaee-Zavareh, M. S., Yeo, Y. H., Wang, T., Guo, Z., Tabrizian, P., Ward, S. C., Barakat, F., Hassanein, T. I., Shravan, D., Veeral, A., Bhoori, S., Mazzaferro, V., Chascsa, D. M. H., Liu, M. C., Aby, E. S., Lake, J. R., Sogbe, M., Sangro, B., Abdelrahim, M., … Yang, J. D. (2024). Impact of pre-transplant immune checkpoint inhibitor use on post-transplant outcomes in HCC: A systematic review and individual patient data meta-analysis. Journal of Hepatology. https://doi.org/10.1016/j.jhep.2024.06.042
Publication Date
Ebrahimi, F., Hagström, H., Sun, J., Bergman, D., Shang, Y., Yang, W., Roelstraete, B., & Ludvigsson, J. F. (2023). Familial coaggregation of MASLD with hepatocellular carcinoma and adverse liver outcomes: Nationwide multigenerational cohort study. Journal of Hepatology, 79(6), 1374–1384. https://doi.org/10.1016/j.jhep.2023.08.018
Publication Date
Simon, T. G., Roelstraete, B., Hagström, H., Loomba, R., & Ludvigsson, J. F. (2023). Progression of non-alcoholic fatty liver disease and long-term outcomes: A nationwide paired liver biopsy cohort study. Journal of Hepatology, 79(6), 1366–1373. https://doi.org/10.1016/j.jhep.2023.08.008
Publication Date
Zhang, X., Sharma, P., Maschmeyer, P., Hu, Y., Lou, M., Kim, J., Fujii, H., Unutmaz, D., Schwabe, R. F., & Winau, F. (2023). GARP on hepatic stellate cells is essential for the development of liver fibrosis. Journal of Hepatology, 79(5), 1214–1225. https://doi.org/10.1016/j.jhep.2023.05.043
Publication Date
Barouki, R., Samson, M., Blanc, E. B., Colombo, M., Zucman-Rossi, J., Lazaridis, K. N., Miller, G. W., & Coumoul, X. (2023). The exposome and liver disease - how environmental factors affect liver health. Journal of Hepatology, 79(2), 492–505. https://doi.org/10.1016/j.jhep.2023.02.034
Publication Date
Tsochatzis, E. A., Watt, K. D., VanWagner, L. B., Verna, E. C., & Berzigotti, A. (2023). Evaluation of recipients with significant comorbidity – Patients with cardiovascular disease. Journal of Hepatology, 78(6), 1089–1104. https://doi.org/10.1016/j.jhep.2023.03.023
Publication Date
Shen, W., Middleton, M. S., Cunha, G. M., Delgado, T. I., Wolfson, T., Gamst, A., Fowler, K. J., Alazraki, A., Trout, A. T., Ohliger, M. A., Shah, S. N., Bashir, M. R., Kleiner, D. E., Loomba, R., Neuschwander-Tetri, B. A., Sanyal, A. J., Zhou, J., Sirlin, C. B., & Lavine, J. E. (2023). Changes in abdominal adipose tissue depots assessed by MRI correlate with hepatic histologic improvement in non-alcoholic steatohepatitis. Journal of Hepatology, 78(2), 238–246. https://doi.org/10.1016/j.jhep.2022.10.027
Publication Date
Peiseler, M., Schwabe, R., Hampe, J., Kubes, P., Heikenwälder, M., & Tacke, F. (2022). Immune mechanisms linking metabolic injury to inflammation and fibrosis in fatty liver disease – novel insights into cellular communication circuits. Journal of Hepatology, 77(4), 1136–1160. https://doi.org/10.1016/j.jhep.2022.06.012
Publication Date
Fondevila, M. F., Fernandez, U., Heras, V., Parracho, T., Gonzalez-Rellan, M. J., Novoa, E., Porteiro, B., Alonso, C., Mayo, R., da Silva Lima, N., Iglesias, C., Filliol, A. A., Senra, A., Delgado, T. C., Woodhoo, A., Herrero, L., Serra, D., Prevot, V., Schwaninger, M., … Nogueiras, R. (2022). Inhibition of carnitine palmitoyltransferase 1A in hepatic stellate cells protects against fibrosis. Journal of Hepatology, 77(1), 15–28. https://doi.org/10.1016/j.jhep.2022.02.003
Publication Date
Garrido, A., Kim, E., Teijeiro, A., Sánchez Sánchez, P., Gallo, R., Nair, A., Matamala Montoya, M., Perna, C., Vicent, G. P., Muñoz, J., Campos-Olivas, R., Melms, J. C., Izar, B., Schwabe, R. F., & Djouder, N. (2022). Histone acetylation of bile acid transporter genes plays a critical role in cirrhosis. Journal of Hepatology, 76(4), 850–861. https://doi.org/10.1016/j.jhep.2021.12.019
Publication Date
Wang, X., Zeldin, S., Shi, H., Zhu, C., Saito, Y., Corey, K. E., Osganian, S. A., Remotti, H. E., Verna, E. C., Pajvani, U. B., Schwabe, R. F., & Tabas, I. (2022). TAZ-induced Cybb contributes to liver tumor formation in non-alcoholic steatohepatitis. Journal of Hepatology, 76(4), 910–920. https://doi.org/10.1016/j.jhep.2021.11.031
Publication Date
Hsieh, J., Molusky, M. M., McCabe, K. M., Fotakis, P., Xiao, T., Tascau, L., Zeana-Schliep, L., DaSilva-Jardine, P., & Tall, A. R. (2022). TTC39B destabilizes retinoblastoma protein promoting hepatic lipogenesis in a sex-specific fashion. Journal of Hepatology, 76(2), 383–393. https://doi.org/10.1016/j.jhep.2021.09.021
Publication Date
Arab, J. P., Díaz, L. A., Baeza, N., Idalsoaga, F., Fuentes-López, E., Arnold, J., Ramírez, C. A., Morales-Arraez, D., Ventura-Cots, M., Alvarado-Tapias, E., Zhang, W., Clark, V., Simonetto, D., Ahn, J. C., Buryska, S., Mehta, T. I., Stefanescu, H., Horhat, A., Bumbu, A., … Bataller, R. (2021). Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. Journal of Hepatology, 75(5), 1026–1033. https://doi.org/10.1016/j.jhep.2021.06.019
Publication Date
Hagström, H., Simon, T. G., Roelstraete, B., Stephansson, O., Söderling, J., & Ludvigsson, J. F. (2021). Maternal obesity increases the risk and severity of NAFLD in offspring. Journal of Hepatology, 75(5), 1042–1048. https://doi.org/10.1016/j.jhep.2021.06.045
Publication Date
Simon, T. G., Roelstraete, B., Hartjes, K., Shah, U., Khalili, H., Arnell, H., & Ludvigsson, J. F. (2021). Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality. Journal of Hepatology, 75(5), 1034–1041. https://doi.org/10.1016/j.jhep.2021.06.034
Publication Date
Song, X., Xu, H., Wang, P., Wang, J., Affo, S., Wang, H., Xu, M., Liang, B., Che, L., Qiu, W., Schwabe, R. F., Chang, T. T., Vogl, M., Pes, G. M., Ribback, S., Evert, M., Chen, X., & Calvisi, D. F. (2021). Focal adhesion kinase (FAK) promotes cholangiocarcinoma development and progression via YAP activation. Journal of Hepatology, 75(4), 888–899. https://doi.org/10.1016/j.jhep.2021.05.018
Publication Date